表紙
市場調査レポート

腹部肥満症:世界の治験レビュー

Abdominal Obesity Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 301444
出版日 ページ情報 英文 107 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
腹部肥満症:世界の治験レビュー Abdominal Obesity Global Clinical Trials Review, H1, 2014
出版日: 2014年05月05日 ページ情報: 英文 107 Pages
概要

当レポートでは、腹部肥満症の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどを提供して、概略以下の構成でお届けいたします。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:代謝障害の治験に対する腹部肥満症の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:代謝障害の治験に対する腹部肥満症の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • 腹部肥満症の治療薬の治験に参加している主要企業

有望薬

最新の治験ニュース

治験プロファイル

  • 主要企業の治験概要
    • Genfit
    • Lithera, Inc.
    • AstraZeneca PLC
    • Sanofi
    • Novartis AG
    • Hanmi Science Co., Ltd.
    • Parry Nutraceuticals
    • Kythera Biopharmaceuticals, Inc.
    • Johnson & Johnson
  • 主要大学・研究機関・病院の治験概要
    • Queen's University
    • Massachusetts General Hospital
    • University of Pittsburgh
    • Wake Forest University
    • Baker IDI Heart and Diabetes Institute
    • Rush University Medical Center
    • UMC Utrecht Holding BV
    • Southeast University
    • Washington University School of Medicine
    • Maastricht University Medical Center

主な臨床プロファイル

付録

図表

目次
Product Code: GDHC2127CTIDB

GlobalData's clinical trial report, "Abdominal Obesity Global Clinical Trials Review, H1, 2014" provides data on the Abdominal Obesity clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Abdominal Obesity. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Obesity. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Abdominal Obesity
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Abdominal Obesity
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Abdominal Obesity Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Abdominal Obesity
    • Sep 30, 2013: Lithera Reports Positive Clinical Study Results From Its Phase 2b RESET Trial for LIPO-202, a Novel Treatment for Abdominal Body Contouring
    • May 07, 2013: Aileron Therapeutics Successfully Completes Stapled Peptide Clinical Trial
    • Mar 12, 2013: Lithera Initiates Phase IIb Clinical Trial Of LIPO-202 Targeting Aesthetic Reduction Of Subcutaneous Abdominal Fat
    • May 10, 2012: Theratechnologies Initiates Preclinical Safety Program For New GRF Peptide, TH1173
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Genfit SA
      • Clinical Trial Overview of Genfit SA
      • Lithera, Inc.
      • Clinical Trial Overview of Lithera, Inc.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Hanmi Science Co., Ltd.
      • Clinical Trial Overview of Hanmi Science Co., Ltd.
      • Parry Nutraceuticals
      • Clinical Trial Overview of Parry Nutraceuticals
      • Kythera Biopharmaceuticals, Inc.
      • Clinical Trial Overview of Kythera Biopharmaceuticals, Inc.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
    • Clinical Trial Overview of Top Institutes / Government
      • Queen's University
      • Clinical Trial Overview of Queen's University
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • University of Pittsburgh
      • Clinical Trial Overview of University of Pittsburgh
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • Baker IDI Heart and Diabetes Institute
      • Clinical Trial Overview of Baker IDI Heart and Diabetes Institute
      • Rush University Medical Center
      • Clinical Trial Overview of Rush University Medical Center
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • Southeast University
      • Clinical Trial Overview of Southeast University
      • Washington University School of Medicine
      • Clinical Trial Overview of Washington University School of Medicine
      • Maastricht University Medical Center
      • Clinical Trial Overview of Maastricht University Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Region, 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Abdominal Obesity Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Abdominal Obesity Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Lithera, Inc., 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanmi Science Co., Ltd., 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Parry Nutraceuticals, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Kythera Biopharmaceuticals, Inc., 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Baker IDI Heart and Diabetes Institute, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Rush University Medical Center, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeast University, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014*

List of Figures

  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Abdominal Obesity Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Abdominal Obesity to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Abdominal Obesity Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Abdominal Obesity Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Abdominal Obesity Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Abdominal Obesity Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top